All In Biotech

Drug Trial Radar · NCT06762457

A First-in-Human Single and Multiple Ascending Dose Study of MT-501

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of MT-501 in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Nov 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Dec 11, 2024

Primary completion

May 22, 2025

Study completion May 22, 2025

Sponsor

Lead sponsor
Mirador Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jan 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Single group
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) with Single and Multiple Ascending Oral Doses of MT-501 in Healthy Adults.

Conditions

  • Healthy Volunteers

Interventions

  • MT-501Drug

    MT-501 Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Outcome Measure: Number of Subjects with non-SAEs and SAESTime frame: Up to 14 days post dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mirador Clinical Department

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.